Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0SN8K
|
|||
| Former ID |
DIB004134
|
|||
| Drug Name |
Anti-CD-20 mab
|
|||
| Synonyms |
Anti-CD-20 mAb (undisclosed indication); Anti-CD-20 mAb (undisclosed indication), PharmAbcine; CD-20 inhibitor (mAb, undisclosed indication), PharmAbcine
Click to Show/Hide
|
|||
| Drug Type |
Monoclonal antibody
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Company |
PharmAbcine
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Leukocyte surface antigen Leu-16 (CD20) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Hematopoietic cell lineage | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2628). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.